Ochre Bio, a biotechnology company developing RNA therapeutics for chronic liver disease, has opened a unique perfusion 'Liver ICU' lab in the Alexandria Centre for Life Sciences.
Patients with late-stage lung and skin cancer may have just won an unlikely ally: the COVID-19 mRNA vaccine. Researchers at ...
The federal government has been—and must remain—a critical partner in foundational technological innovation and research ...
ProQR ( ($PRQR) ) has shared an announcement. On October 20, 2025, ProQR Therapeutics announced that it received Clinical Trial Application (CTA) ...
An international team led by Monash University researchers has uncovered the genetic code governing the way genetic mutations ...
Lung cancer and melanoma patients immunized with this formula doubled their chances of surviving three years, according to a ...